Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2014 Mar:20:42-6.
doi: 10.1016/j.ijid.2013.12.003. Epub 2014 Jan 6.

Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study

Jaffar A Al-Tawfiq  1 , Hisham Momattin  2 , Jean Dib  2 , Ziad A Memish  3
Affiliations
Case Reports

Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study

Jaffar A Al-Tawfiq et al. Int J Infect Dis. 2014 Mar.

Abstract

Background: The Middle East respiratory syndrome coronavirus (MERS-CoV) has been reported to have a high case-fatality rate. Currently, there is no specific therapy or vaccine with proven effectiveness for MERS-CoV infections.

Methods: A combination of ribavirin and interferon therapy was used for the treatment of five MERS-CoV-positive patients. We reviewed the therapeutic schedule and the outcome of these patients.

Results: All patients were critically ill with acute respiratory distress syndrome treated with adjunctive corticosteroids and were on mechanical ventilation at the time of initiation of therapy. The median time from admission to therapy with ribavirin and interferon was 19 (range 10-22) days. None of the patients responded to the supportive or therapeutic interventions and all died of their illness.

Conclusions: While ribavirin and interferon may be effective in some patients, our practical experience suggests that critically ill patients with multiple comorbidities who are diagnosed late in the course of their illness may not benefit from combination antiviral therapy as preclinical data suggest. There is clearly an urgent need for a novel effective antiviral therapy for this emerging global threat.

Keywords: Interferon; MERS-CoV; Pegylated interferon; Ribavirin.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Median, minimum, and maximum values for amylase, lipase, and lactate dehydrogenase (LDH).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Penttinen P.M., Kaasik-Aaslav K., Friaux A., Donachie A., Sudre B., Amato-Gauci A.J. Taking stock of the first 133 MERS coronavirus cases globally—is the epidemic changing? Euro Surveill. 2013;18 pii: 20596. - PubMed
    1. World Health Orzination . WHO; Geneva: 2013. Middle East respiratory syndrome coronavirus (MERS-CoV)—update. Available at: http://www.who.int/csr/don/2013_12_02/en/index.html last (accessed December 3)
    1. Zaki A.M., van Boheemen S., Bestebroer T.M., Osterhaus A.D., Fouchier R.A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367:1814–1820. - PubMed
    1. Omrani A.S., Matin M.A., Haddad Q., Al-Nakhli D., Memish Z.A., Albarrak A.M. A family cluster of Middle East respiratory syndrome coronavirus infections related to a likely unrecognized asymptomatic or mild case. Int J Infect Dis. 2013;17:e668–e672. - PMC - PubMed
    1. Assiri A., Al-Tawfiq J.A., Al-Rabeeah A.A., Al-Rabiah F.A., Al-Hajjar S., Al-Barrak A. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis. 2013;13:752–761. - PMC - PubMed

MeSH terms